Krognes Steve E. - Insider Non-Derivative Transactions at Denali Therapeutics Inc. (DNLI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 20, 2024, Krognes Steve E.'s relationship to Denali Therapeutics Inc. (DNLI) is Director, and currently has 32,677 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DNLI insiders.
Data Source: SEC.
Krognes Steve E. - Insider Non-Derivative Transactions of DNLI Common Stock
Krognes Steve E. - Insider Non-Derivative Transactions at DNLI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 21, 2024 | Sell -- (Common Stock) | 1727 | 23.79 | 32677 |
| Jul 2, 2024 | Sell -- (Common Stock) | 100 | 22.8 | 34404 |
| Jul 2, 2024 | Sell -- (Common Stock) | 29900 | 22.12 | 34504 |
| Jun 14, 2024 | Sell -- (Common Stock) | 688 | 21.79 | 52620 |
| Jun 1, 2024 | Acquisition -- (Common Stock) | 5967 | 0 | 53308 |
| Apr 2, 2024 | Sell -- (Common Stock) | 92500 | 20.5 | 47341 |
| Feb 14, 2024 | Sell -- (Common Stock) | 2750 | 17.29 | 139841 |
| Jan 6, 2024 | Sell -- (Common Stock) | 3208 | 19.43 | 142591 |
| Aug 22, 2023 | Sell -- (Common Stock) | 1419 | 22.6 | 145799 |
| Jun 2, 2023 | Acquisition -- (Common Stock) | 4216 | 0 | 147218 |
| Feb 14, 2023 | Sell -- (Common Stock) | 2119 | 30.1 | 143002 |
| Feb 9, 2023 | Sell -- (Common Stock) | 1377 | 30.88 | 145121 |
| Jan 6, 2023 | Sell -- (Common Stock) | 2970 | 28.44 | 146498 |